TreeWAS – Variant ID: rs4895694

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
# Top node	1.000	0.000
Chapter X Diseases of the respiratory system	1.000	0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes	1.000	0.000
Chapter II Neoplasms	0.999	0.001
J09-J18 Influenza and pneumonia	0.996	0.004
J20-J22 Other acute lower respiratory infections	0.992	0.008
J18 Pneumonia, organism unspecified	0.986	0.014
J22 Unspecified acute lower respiratory infection	0.986	0.014
Chapter VI Diseases of the nervous system	0.986	0.014
Chapter XX External causes of morbidity and mortality	0.985	0.015
T36-T50 Poisoning by drugs, medicaments and biological substances	0.983	0.017
J18.9 Pneumonia, unspecified	0.981	0.019
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.972	0.028
J40-J47 Chronic lower respiratory diseases	0.971	0.029
G35-G37 Demyelinating diseases of the central nervous system	0.967	0.033
S70-S79 Injuries to the hip and thigh	0.965	0.035
J44 Other chronic obstructive pulmonary disease	0.959	0.041
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.958	0.042
G35 Multiple sclerosis	0.957	0.043
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.955	0.045
Chapter V Mental and behavioural disorders	0.955	0.045
D00-D09 In situ neoplasms	0.949	0.051
C34 Malignant neoplasm of bronchus and lung	0.947	0.053
J44.9 Chronic obstructive pulmonary disease, unspecified	0.946	0.054
S10-S19 Injuries to the neck	0.945	0.055
G00-G09 Inflammatory diseases of the central nervous system	0.944	0.056
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.934	0.066
S72 Fracture of femur	0.930	0.070
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.926	0.074
C64-C68 Malignant neoplasms of urinary tract	0.924	0.076
J80-J84 Other respiratory diseases principally affecting the interstitium	0.916	0.084
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.916	0.084
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.915	0.085
T51 Toxic effect of alcohol	0.909	0.091
C64 Malignant neoplasm of kidney, except renal pelvis	0.907	0.093
D03 Melanoma in situ	0.902	0.098
D70-D77 Other diseases of blood and blood-forming organs	0.899	0.101
J15 Bacterial pneumonia, not elsewhere classified	0.897	0.103
C34.9 Bronchus or lung, unspecified	0.897	0.103
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection	0.889	0.111
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.879	0.121
T51.0 Ethanol	0.877	0.123
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.866	0.134
D70 Agranulocytosis	0.863	0.137
J47 Bronchiectasis	0.861	0.139
S72.0 Fracture of neck of femur	0.860	0.140
C97 Malignant neoplasms of independent (primary) multiple sites	0.855	0.145
Y51 Drugs primarily affecting the autonomic nervous system	0.855	0.145
Chapter VIII Diseases of the ear and mastoid process	0.852	0.148
T20-T25 Burns and corrosions of external body surface, specified by site	0.849	0.151
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.846	0.154
S14 Injury of nerves and spinal cord at neck level	0.840	0.160
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.838	0.162
D03.3 Melanoma in situ of other and unspecified parts of face	0.832	0.168
S90-S99 Injuries to the ankle and foot	0.830	0.170
F80-F89 Disorders of psychological development	0.828	0.172
S72.4 Fracture of lower end of femur	0.823	0.177
S79 Other and unspecified injuries of hip and thigh	0.823	0.177
C09 Malignant neoplasm of tonsil	0.823	0.177
C60-C63 Malignant neoplasms of male genital organs	0.819	0.181
J81 Pulmonary oedema	0.819	0.181
S20-S29 Injuries to the thorax	0.817	0.183
C34.1 Upper lobe, bronchus or lung	0.815	0.185
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.814	0.186
Chapter XXII Codes for special purposes	0.814	0.186
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.813	0.187
W20-W49 Exposure to inanimate mechanical forces	0.812	0.188
J14 Pneumonia due to Haemophilus influenzae	0.811	0.189
J15.2 Pneumonia due to staphylococcus	0.810	0.190
S72.00 Fracture of neck of femur (closed)	0.810	0.190
G70-G73 Diseases of myoneural junction and muscle	0.810	0.190
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.808	0.192
F10 Mental and behavioural disorders due to use of alcohol	0.806	0.194
V10-V19 Pedal cyclist injured in transport accident	0.805	0.195
D73 Diseases of spleen	0.801	0.199
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.795	0.205
J10 Influenza due to identified influenza virus	0.794	0.206
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.793	0.207
H90-H95 Other disorders of ear	0.792	0.208
W50-W64 Exposure to animate mechanical forces	0.792	0.208
X58-X59 Accidental exposure to other and unspecified factors	0.789	0.211
F99-F99 Unspecified mental disorder	0.788	0.212
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.788	0.212
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.787	0.213
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.783	0.217
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.782	0.218
C10 Malignant neoplasm of oropharynx	0.779	0.221
T43.2 Other and unspecified antidepressants	0.777	0.223
J20 Acute bronchitis	0.777	0.223
G09 Sequelae of inflammatory diseases of central nervous system	0.776	0.224
J12 Viral pneumonia, not elsewhere classified	0.773	0.227
F00-F09 Organic, including symptomatic, mental disorders	0.773	0.227
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.771	0.229
S50-S59 Injuries to the elbow and forearm	0.769	0.231
D03.4 Melanoma in situ of scalp and neck	0.768	0.232
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.767	0.233
Y42.7 Androgens and anabolic congeners	0.767	0.233
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.767	0.233
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.767	0.233
C34.3 Lower lobe, bronchus or lung	0.766	0.234
J40 Bronchitis, not specified as acute or chronic	0.766	0.234
S14.1 Other and unspecified injuries of cervical spinal cord	0.766	0.234
D04 Carcinoma in situ of skin	0.764	0.236
X60-X84 Intentional self-harm	0.764	0.236
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.761	0.238
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.761	0.238
S12 Fracture of neck	0.760	0.240
D02 Carcinoma in situ of middle ear and respiratory system	0.758	0.241
C32 Malignant neoplasm of larynx	0.757	0.243
T42.4 Benzodiazepines	0.756	0.244
J95-J99 Other diseases of the respiratory system	0.756	0.244
J46 Status asthmaticus	0.755	0.245
W00-W19 Falls	0.755	0.245
C40-C41 Malignant neoplasms of bone and articular cartilage	0.753	0.247
G03 Meningitis due to other and unspecified causes	0.751	0.249
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.750	0.250
G06 Intracranial and intraspinal abscess and granuloma	0.749	0.251
F10.2 Dependence syndrome	0.749	0.251
C09.9 Tonsil, unspecified	0.748	0.252
T58 Toxic effect of carbon monoxide	0.747	0.253
X10-X19 Contact with heat and hot substances	0.747	0.253
S72.40 Fracture of lower end of femur (closed)	0.747	0.253
J17 Pneumonia in diseases classified elsewhere	0.746	0.254
Y00-Y09 Assault	0.746	0.254
J15.4 Pneumonia due to other streptococci	0.745	0.255
H90 Conductive and sensorineural hearing loss	0.745	0.255
Y53 Agents primarily affecting the gastro-intestinal system	0.744	0.256
T15-T19 Effects of foreign body entering through natural orifice	0.742	0.258
S20 Superficial injury of thorax	0.742	0.258
T79-T79 Certain early complications of trauma	0.741	0.259
Y49 Psychotropic drugs, not elsewhere classified	0.740	0.260
T59 Toxic effect of other gases, fumes and vapours	0.740	0.260
Y48 Anaesthetics and therapeutic gases	0.739	0.261
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.739	0.261
T46 Poisoning by agents primarily affecting the cardiovascular system	0.737	0.262
G00 Bacterial meningitis, not elsewhere classified	0.737	0.263
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.735	0.265
D80-D89 Certain disorders involving the immune mechanism	0.735	0.265
S40-S49 Injuries to the shoulder and upper arm	0.735	0.265
S11 Open wound of neck	0.734	0.266
C50-C50 Malignant neoplasm of breast	0.734	0.266
J80 Adult respiratory distress syndrome	0.733	0.267
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.732	0.268
S19 Other and unspecified injuries of neck	0.731	0.269
J00-J06 Acute upper respiratory infections	0.730	0.270
F81 Specific developmental disorders of scholastic skills	0.730	0.270
Y95 Nosocomial condition	0.729	0.271
V20-V29 Motorcycle rider injured in transport accident	0.727	0.273
Y46 Antiepileptics and anti-Parkinsonism drugs	0.725	0.275
C92 Myeloid leukaemia	0.724	0.276
Y52 Agents primarily affecting the cardiovascular system	0.724	0.276
V40-V49 Car occupant injured in transport accident	0.723	0.277
T42.1 Iminostilbenes	0.722	0.278
S79.9 Unspecified injury of hip and thigh	0.722	0.278
G80-G83 Cerebral palsy and other paralytic syndromes	0.719	0.281
D73.0 Hyposplenism	0.719	0.281
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
T33-T35 Frostbite	0.717	0.283
T26-T28 Burns and corrosions confined to eye and internal organs	0.717	0.283
T00-T07 Injuries involving multiple body regions	0.717	0.283
S72.2 Subtrochanteric fracture	0.716	0.284
X20-X29 Contact with venomous animals and plants	0.715	0.285
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.714	0.286
J09 Influenza due to certain identified influenza virus	0.714	0.286
S10 Superficial injury of neck	0.712	0.288
J21 Acute bronchiolitis	0.711	0.288
D05 Carcinoma in situ of breast	0.710	0.290
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.710	0.290
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.710	0.290
X50-X57 Overexertion, travel and privation	0.709	0.291
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.709	0.291
J18.8 Other pneumonia, organism unspecified	0.707	0.293
J18.2 Hypostatic pneumonia, unspecified	0.707	0.293
Y35-Y36 Legal intervention and operations of war	0.706	0.294
Y10-Y34 Event of undetermined intent	0.706	0.294
X85-X99 Assault	0.706	0.294
X30-X39 Exposure to forces of nature	0.706	0.294
X00-X09 Exposure to smoke, fire and flames	0.706	0.294
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.706	0.294
W75-W84 Other accidental threats to breathing	0.706	0.294
W65-W74 Accidental drowning and submersion	0.706	0.294
V98-V99 Other and unspecified transport accidents	0.706	0.294
V95-V97 Air and space transport accidents	0.706	0.294
V90-V94 Water transport accidents	0.706	0.294
V70-V79 Bus occupant injured in transport accident	0.706	0.294
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.706	0.294
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.706	0.294
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.706	0.294
V01-V09 Pedestrian injured in transport accident	0.706	0.294
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.705	0.295
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.705	0.295
T41 Poisoning by anaesthetics and therapeutic gases	0.705	0.295
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.705	0.295
T36 Poisoning by systemic antibiotics	0.705	0.295
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.703	0.297
S90 Superficial injury of ankle and foot	0.703	0.297
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.702	0.297
C05 Malignant neoplasm of palate	0.702	0.297
T63 Toxic effect of contact with venomous animals	0.702	0.298
C88 Malignant immunoproliferative diseases	0.701	0.299
G04 Encephalitis, myelitis and encephalomyelitis	0.701	0.299
S72.1 Pertrochanteric fracture	0.699	0.300
D03.6 Melanoma in situ of upper limb, including shoulder	0.698	0.302
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.697	0.302
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.697	0.303
C38 Malignant neoplasm of heart, mediastinum and pleura	0.697	0.303
C31 Malignant neoplasm of accessory sinuses	0.697	0.303
C30 Malignant neoplasm of nasal cavity and middle ear	0.697	0.303
C37 Malignant neoplasm of thymus	0.697	0.303
C33 Malignant neoplasm of trachea	0.697	0.303
J41 Simple and mucopurulent chronic bronchitis	0.696	0.304
S73 Dislocation, sprain and strain of joint and ligaments of hip	0.695	0.304
C34.0 Main bronchus	0.695	0.304
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.694	0.306
C84 Peripheral and cutaneous T-cell lymphomas	0.694	0.306
C01 Malignant neoplasm of base of tongue	0.694	0.306
G36 Other acute disseminated demyelination	0.693	0.306
S78 Traumatic amputation of hip and thigh	0.692	0.308
S77 Crushing injury of hip and thigh	0.692	0.308
S76 Injury of muscle and tendon at hip and thigh level	0.692	0.308
S75 Injury of blood vessels at hip and thigh level	0.692	0.308
S74 Injury of nerves at hip and thigh level	0.692	0.308
J84 Other interstitial pulmonary diseases	0.692	0.308
J18.0 Bronchopneumonia, unspecified	0.691	0.309
G70 Myasthenia gravis and other myoneural disorders	0.690	0.310
F10.6 Amnesic syndrome	0.690	0.310
D75 Other diseases of blood and blood-forming organs	0.689	0.311
D10-D36 Benign neoplasms	0.689	0.311
T65 Toxic effect of other and unspecified substances	0.687	0.313
T62 Toxic effect of other noxious substances eaten as food	0.687	0.313
T61 Toxic effect of noxious substances eaten as seafood	0.687	0.313
T60 Toxic effect of pesticides	0.687	0.313
T57 Toxic effect of other inorganic substances	0.687	0.313
T56 Toxic effect of metals	0.687	0.313
T54 Toxic effect of corrosive substances	0.687	0.313
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.687	0.313
T52 Toxic effect of organic solvents	0.687	0.313
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.687	0.313
T55 Toxic effect of soaps and detergents	0.687	0.313
C81 Hodgkin's disease	0.687	0.313
Y59 Other and unspecified vaccines and biological substances	0.685	0.315
Y58 Bacterial vaccines	0.685	0.315
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.685	0.315
Y50 Central nervous system stimulants, not elsewhere classified	0.685	0.315
Y47 Sedatives, hypnotics and antianxiety drugs	0.685	0.315
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.684	0.315
F70-F79 Mental retardation	0.684	0.315
Y40 Systemic antibiotics	0.684	0.316
C49 Malignant neoplasm of other connective and soft tissue	0.681	0.319
D01 Carcinoma in situ of other and unspecified digestive organs	0.680	0.319
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.680	0.319
J18.1 Lobar pneumonia, unspecified	0.680	0.320
T43.0 Tricyclic and tetracyclic antidepressants	0.679	0.321
C34.8 Overlapping lesion of bronchus and lung	0.679	0.321
D07 Carcinoma in situ of other and unspecified genital organs	0.679	0.321
T25 Burn and corrosion of ankle and foot	0.678	0.322
S17 Crushing injury of neck	0.677	0.323
S15 Injury of blood vessels at neck level	0.677	0.323
S13 Dislocation, sprain and strain of joints and ligaments at neck level	0.677	0.323
S18 Traumatic amputation at neck level	0.677	0.323
S16 Injury of muscle and tendon at neck level	0.677	0.323
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.677	0.323
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.677	0.323
G01 Meningitis in bacterial diseases classified elsewhere	0.677	0.323
V17 Pedal cyclist injured in collision with fixed or stationary object	0.676	0.324
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.675	0.325
H60-H62 Diseases of external ear	0.675	0.325
G60 Hereditary and idiopathic neuropathy	0.675	0.325
C10.9 Oropharynx, unspecified	0.674	0.326
J15.0 Pneumonia due to Klebsiella pneumoniae	0.674	0.326
C91 Lymphoid leukaemia	0.674	0.326
D03.7 Melanoma in situ of lower limb, including hip	0.673	0.327
F10.4 Withdrawal state with delirium	0.673	0.327
T43.5 Other and unspecified antipsychotics and neuroleptics	0.672	0.328
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.671	0.329
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.669	0.330
C95 Leukaemia of unspecified cell type	0.669	0.330
C94 Other leukaemias of specified cell type	0.669	0.330
C93 Monocytic leukaemia	0.669	0.330
C86 Other specified types of T/NK-cell lymphoma	0.669	0.330
F99 Mental disorder, not otherwise specified	0.669	0.331
S72.9 Fracture of femur, part unspecified	0.667	0.333
S72.8 Fractures of other parts of femur	0.667	0.333
S72.7 Multiple fractures of femur	0.667	0.333
H93 Other disorders of ear, not elsewhere classified	0.667	0.333
W49 Exposure to other and unspecified inanimate mechanical forces	0.666	0.334
C85.1 B-cell lymphoma, unspecified	0.666	0.334
G12 Spinal muscular atrophy and related syndromes	0.666	0.334
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.665	0.335
S70 Superficial injury of hip and thigh	0.665	0.335
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.665	0.335
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.664	0.336
C13 Malignant neoplasm of hypopharynx	0.664	0.336
C11 Malignant neoplasm of nasopharynx	0.664	0.336
C08 Malignant neoplasm of other and unspecified major salivary glands	0.664	0.336
C06 Malignant neoplasm of other and unspecified parts of mouth	0.664	0.336
C04 Malignant neoplasm of floor of mouth	0.664	0.336
C03 Malignant neoplasm of gum	0.664	0.336
C00 Malignant neoplasm of lip	0.664	0.336
C12 Malignant neoplasm of pyriform sinus	0.664	0.336
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.663	0.336
C68 Malignant neoplasm of other and unspecified urinary organs	0.662	0.338
C65 Malignant neoplasm of renal pelvis	0.662	0.338
C83 Diffuse non-Hodgkin's lymphoma	0.662	0.338
D35 Benign neoplasm of other and unspecified endocrine glands	0.662	0.338
F81.9 Developmental disorder of scholastic skills, unspecified	0.660	0.340
F03 Unspecified dementia	0.659	0.341
J90-J94 Other diseases of pleura	0.659	0.341
C02 Malignant neoplasm of other and unspecified parts of tongue	0.659	0.341
J82 Pulmonary eosinophilia, not elsewhere classified	0.657	0.343
S20.8 Superficial injuries of other and unspecified parts of thorax	0.657	0.343
C66 Malignant neoplasm of ureter	0.655	0.345
T90 Sequelae of injuries of head	0.654	0.345
C82.3 Follicular lymphoma grade IIIa	0.654	0.346
W29 Contact with other powered hand tools and household machinery	0.653	0.347
T51.8 Other alcohols	0.651	0.348
T51.3 Fusel oil	0.651	0.348
T51.2 2-Propanol	0.651	0.348
T51.1 Methanol	0.651	0.348
C61 Malignant neoplasm of prostate	0.651	0.349
Y57 Other and unspecified drugs and medicaments	0.650	0.350
G90-G99 Other disorders of the nervous system	0.648	0.352
Y41 Other systemic anti-infectives and antiparasitics	0.648	0.352
C34.2 Middle lobe, bronchus or lung	0.647	0.353
D03.9 Melanoma in situ, unspecified	0.647	0.353
D03.8 Melanoma in situ of other sites	0.647	0.353
D03.2 Melanoma in situ of ear and external auricular canal	0.647	0.353
D03.1 Melanoma in situ of eyelid, including canthus	0.647	0.353
D03.0 Melanoma in situ of lip	0.647	0.353
D72 Other disorders of white blood cells	0.647	0.353
F60-F69 Disorders of adult personality and behaviour	0.647	0.353
S50 Superficial injury of forearm	0.646	0.354
T50.9 Other and unspecified drugs, medicaments and biological substances	0.646	0.354
D74 Methaemoglobinaemia	0.644	0.355
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.644	0.355
D71 Functional disorders of polymorphonuclear neutrophils	0.644	0.355
D04.3 Skin of other and unspecified parts of face	0.644	0.356
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.643	0.356
J15.9 Bacterial pneumonia, unspecified	0.643	0.357
J15.8 Other bacterial pneumonia	0.643	0.357
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.643	0.357
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.643	0.357
J15.5 Pneumonia due to Escherichia coli	0.643	0.357
J15.3 Pneumonia due to streptococcus, group B	0.643	0.357
G20-G26 Extrapyramidal and movement disorders	0.643	0.357
V80-V89 Other land transport accidents	0.642	0.357
T66-T78 Other and unspecified effects of external causes	0.641	0.359
C62 Malignant neoplasm of testis	0.641	0.359
T47.1 Other antacids and anti-gastric-secretion drugs	0.640	0.360
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.638	0.361
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.637	0.362
W10 Fall on and from stairs and steps	0.637	0.363
J92 Pleural plaque	0.636	0.364
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.636	0.364
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.635	0.364
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.635	0.365
Y54.3 Benzothiadiazine derivatives	0.632	0.368
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.630	0.370
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.630	0.370
Y60-Y69 Misadventures to patients during surgical and medical care	0.630	0.370
T43.9 Psychotropic drug, unspecified	0.630	0.370
T43.8 Other psychotropic drugs, not elsewhere classified	0.630	0.370
T43.6 Psychostimulants with abuse potential	0.630	0.370
T43.4 Butyrophenone and thioxanthene neuroleptics	0.630	0.370
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.630	0.370
F20 Schizophrenia	0.628	0.372
H90.2 Conductive hearing loss, unspecified	0.628	0.372
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.626	0.374
D10 Benign neoplasm of mouth and pharynx	0.625	0.375
G11 Hereditary ataxia	0.624	0.376
C90 Multiple myeloma and malignant plasma cell neoplasms	0.624	0.376
S71 Open wound of hip and thigh	0.622	0.377
C07 Malignant neoplasm of parotid gland	0.622	0.378
D02.0 Larynx	0.622	0.378
J95 Postprocedural respiratory disorders, not elsewhere classified	0.622	0.378
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.621	0.379
T42.5 Mixed antiepileptics, not elsewhere classified	0.621	0.379
T42.3 Barbiturates	0.621	0.379
T42.2 Succinimides and oxazolidinediones	0.621	0.379
T42.0 Hydantoin derivatives	0.621	0.379
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.620	0.380
T45.2 Vitamins, not elsewhere classified	0.619	0.381
X58 Exposure to other specified factors	0.619	0.381
S56 Injury of muscle and tendon at forearm level	0.619	0.381
D06 Carcinoma in situ of cervix uteri	0.618	0.381
D35.2 Pituitary gland	0.618	0.382
T51.9 Alcohol, unspecified	0.617	0.382
U89 Agent resistant to other and unspecified antibiotics	0.617	0.383
S72.01 Fracture of neck of femur (open)	0.617	0.383
D05.1 Intraductal carcinoma in situ	0.617	0.383
J10.0 Influenza with pneumonia, influenza virus identified	0.616	0.384
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.614	0.385
F11 Mental and behavioural disorders due to use of opioids	0.614	0.386
W21 Striking against or struck by sports equipment	0.613	0.387
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.613	0.387
G03.9 Meningitis, unspecified	0.613	0.387
D55-D59 Haemolytic anaemias	0.613	0.387
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.613	0.387
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.613	0.387
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.613	0.387
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.613	0.387
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.613	0.387
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.613	0.387
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.613	0.387
Y51.1 Other parasympathomimetics [cholinergics]	0.613	0.387
Y51.0 Anticholinesterase agents	0.613	0.387
J12.9 Viral pneumonia, unspecified	0.613	0.387
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.612	0.388
F80 Specific developmental disorders of speech and language	0.612	0.388
W19 Unspecified fall	0.611	0.389
X40-X49 Accidental poisoning by and exposure to noxious substances	0.610	0.390
G81 Hemiplegia	0.610	0.390
J20.8 Acute bronchitis due to other specified organisms	0.609	0.391
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.609	0.391
T23 Burn and corrosion of wrist and hand	0.609	0.391
T21 Burn and corrosion of trunk	0.609	0.391
T20 Burn and corrosion of head and neck	0.609	0.391
J92.9 Pleural plaque without asbestos	0.609	0.391
Y91 Evidence of alcohol involvement determined by level of intoxication	0.608	0.392
S20.2 Contusion of thorax	0.608	0.392
D04.4 Skin of scalp and neck	0.607	0.392
S91 Open wound of ankle and foot	0.607	0.393
S72.3 Fracture of shaft of femur	0.607	0.393
D73.5 Infarction of spleen	0.607	0.393
F18 Mental and behavioural disorders due to use of volatile solvents	0.606	0.394
F16 Mental and behavioural disorders due to use of hallucinogens	0.606	0.394
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.606	0.394
F14 Mental and behavioural disorders due to use of cocaine	0.606	0.394
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.606	0.394
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.606	0.394
Y45.8 Other analgesics and antipyretics	0.606	0.394
J60-J70 Lung diseases due to external agents	0.606	0.394
Y45.5 4-Aminophenol derivatives	0.605	0.395
G70.0 Myasthenia gravis	0.605	0.395
S92 Fracture of foot, except ankle	0.604	0.396
G37 Other demyelinating diseases of central nervous system	0.604	0.396
W20 Struck by thrown, projected or falling object	0.604	0.396
F12 Mental and behavioural disorders due to use of cannabinoids	0.603	0.396
X59 Exposure to unspecified factor	0.603	0.397
S14.6 Injury of other and unspecified nerves of neck	0.602	0.397
S14.5 Injury of cervical sympathetic nerves	0.602	0.397
S14.4 Injury of peripheral nerves of neck	0.602	0.397
S14.3 Injury of brachial plexus	0.602	0.397
S14.2 Injury of nerve root of cervical spine	0.602	0.397
S14.0 Concussion and oedema of cervical spinal cord	0.602	0.397
W44 Foreign body entering into or through eye or natural orifice	0.602	0.397
F30-F39 Mood [affective] disorders	0.602	0.398
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.602	0.398
F10.3 Withdrawal state	0.602	0.398
T43.3 Phenothiazine antipsychotics and neuroleptics	0.602	0.398
T40.4 Other synthetic narcotics	0.602	0.398
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.601	0.399
Y90 Evidence of alcohol involvement determined by blood alcohol level	0.601	0.399
Y98 Lifestyle-related condition	0.601	0.399
Y97 Environmental-pollution-related condition	0.601	0.399
Y96 Work-related condition	0.601	0.399
Y44 Agents primarily affecting blood constituents	0.600	0.400
T39.0 Salicylates	0.600	0.400
W51 Striking against or bumped into by another person	0.599	0.401
X68 Intentional self-poisoning by and exposure to pesticides	0.598	0.402
S99 Other and unspecified injuries of ankle and foot	0.598	0.402
F40-F48 Neurotic, stress-related and somatoform disorders	0.597	0.402
D11 Benign neoplasm of major salivary glands	0.596	0.404
Y48.2 Other and unspecified general anaesthetics	0.596	0.404
D80 Immunodeficiency with predominantly antibody defects	0.596	0.404
D21 Other benign neoplasms of connective and other soft tissue	0.595	0.405
S98 Traumatic amputation of ankle and foot	0.595	0.405
S97 Crushing injury of ankle and foot	0.595	0.405
S96 Injury of muscle and tendon at ankle and foot level	0.595	0.405
S95 Injury of blood vessels at ankle and foot level	0.595	0.405
S94 Injury of nerves at ankle and foot level	0.595	0.405
F84 Pervasive developmental disorders	0.594	0.406
F89 Unspecified disorder of psychological development	0.594	0.406
F88 Other disorders of psychological development	0.594	0.406
F83 Mixed specific developmental disorders	0.594	0.406
F82 Specific developmental disorder of motor function	0.594	0.406
J02 Acute pharyngitis	0.593	0.407
Y53.1 Other antacids and anti-gastric-secretion drugs	0.592	0.408
S90.0 Contusion of ankle	0.591	0.409
S72.41 Fracture of lower end of femur (open)	0.590	0.410
S79.8 Other specified injuries of hip and thigh	0.590	0.410
S79.7 Multiple injuries of hip and thigh	0.590	0.410
C09.8 Overlapping lesion of tonsil	0.590	0.410
C09.1 Tonsillar pillar (anterior) (posterior)	0.590	0.410
C09.0 Tonsillar fossa	0.590	0.410
Y45.2 Propionic acid derivatives	0.589	0.410
J11 Influenza, virus not identified	0.589	0.411
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.589	0.411
G00.1 Pneumococcal meningitis	0.588	0.412
H65-H75 Diseases of middle ear and mastoid	0.588	0.412
G72 Other myopathies	0.587	0.412
C63 Malignant neoplasm of other and unspecified male genital organs	0.587	0.413
C60 Malignant neoplasm of penis	0.587	0.413
C49.1 Connective and soft tissue of upper limb, including shoulder	0.587	0.413
S12.2 Fracture of other specified cervical vertebra	0.586	0.414
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.586	0.414
S26 Injury of heart	0.586	0.414
S25 Injury of blood vessels of thorax	0.586	0.414
S24 Injury of nerves and spinal cord at thorax level	0.586	0.414
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.586	0.414

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations